Israel Englander 10x Genomics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 15,000 shares of TXG stock, worth $169,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,000

Previous 70,000 78.57%

Holding current value

$169,350

Previous $1.58 Million 86.39%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $954,337 - $1.54 Million	72,408 Added 7.88%	991,165 $14.2 Million
Q3 2024 Nov 14, 2024	SELL	$15.71 - $23.49 $6.94 Million - $10.4 Million	-441,994 Reduced 32.48%	918,757 $20.7 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $4.44 Million - $8.53 Million	228,323 Added 20.16%	1,360,751 $26.5 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $30.9 Million - $46.6 Million	857,293 Added 311.59%	1,132,428 $42.5 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $6.4 Million - $10.7 Million	186,581 Added 210.7%	275,135 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $6.9 Million - $7.95 Million	-135,427 Reduced 60.46%	88,554 $4.94 Million
Q1 2023 May 15, 2023	SELL	$35.33 - $55.79 $35 Million - $55.2 Million	-989,413 Reduced 81.54%	223,981 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $24.4 Million - $41.3 Million	999,487 Added 467.25%	1,213,394 $44.2 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $4.18 Million - $7.72 Million	146,891 Added 219.19%	213,907 $6.09 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $4.7 Million - $10.5 Million	-127,300 Reduced 65.51%	67,016 $3.03 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $7.01 Million - $18.4 Million	125,914 Added 184.08%	194,316 $14.8 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $9.24 Million - $12.5 Million	68,402 New	68,402 $10.2 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $21.1 Million - $31.7 Million	-156,873 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $25.6 Million - $35.9 Million	-182,590 Reduced 53.79%	156,873 $28.4 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $36.1 Million - $46.7 Million	285,238 Added 526.03%	339,463 $48.1 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $4.74 Million - $6.78 Million	54,225 New	54,225 $6.76 Million
Q2 2020 Aug 14, 2020	SELL	$58.39 - $89.31 $5.31 Million - $8.12 Million	-90,888 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $3.39 Million - $7.02 Million	65,802 Added 262.31%	90,888 $5.66 Million
Q4 2019 Feb 14, 2020	SELL	$46.07 - $79.54 $1.08 Million - $1.86 Million	-23,420 Reduced 48.28%	25,086 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $2.42 Million - $3.01 Million	48,506 New	48,506 $2.44 Million

Others Institutions Holding TXG

# of Institutions

302

Shares Held

96.5M

Call Options Held

76.4K

Put Options Held

132K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.07B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account